檢索結果 - Haluska, Paul

IGF-1 Receptor Inhibitors in Clinical Trials—Early Lessons 由 Weroha, S. John, Haluska, Paul

獲取全文 獲取全文 獲取全文

IGF System in Cancer 由 Weroha, S. John, Haluska, Paul

獲取全文 獲取全文 獲取全文

Cixutumumab 由 McKian, Kevin P, Haluska, Paul

獲取全文 獲取全文 獲取全文

Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment 由 Lodhia, Kunal Amratlal, Tienchaiananda, Piyawan, Haluska, Paul

獲取全文 獲取全文 獲取全文

Patient-Derived Xenograft Models in Gynecological Malignancies 由 Scott, Clare L., Mackay, Helen J, Haluska, Paul

獲取全文 獲取全文 獲取全文

Can we unlock the potential of IGF-1R inhibition in cancer therapy? 由 King, Helen, Aleksic, Tamara, Haluska, Paul, Macaulay, Valentine M.

獲取全文 獲取全文 獲取全文

Patient-Derived Xenograft Models to Improve Targeted Therapy in Epithelial Ovarian Cancer Treatment 由 Scott, Clare L., Becker, Marc A., Haluska, Paul, Samimi, Goli

獲取全文 獲取全文 獲取全文

Cancer and Pregnancy: Parallels in Growth, Invasion, and Immune Modulation and Implications for Cancer Therapeutic Agents 由 Holtan, Shernan G., Creedon, Douglas J., Haluska, Paul, Markovic, Svetomir N.

獲取全文 獲取全文

A Novel Neutralizing Antibody Targeting Pregnancy-Associated Plasma Protein-A Inhibits Ovarian Cancer Growth and Ascites Accumulation in Patient Mouse Tumorgrafts 由 Becker, Marc A., Haluska, Paul, Bale, Laurie K., Oxvig, Claus, Conover, Cheryl A.

獲取全文 獲取全文 獲取全文

Hormone response in ovarian cancer: time to reconsider as a clinical target? 由 Modugno, Francesmary, Laskey, Robin, Smith, Ashlee L, Andersen, Courtney L, Haluska, Paul, Oesterreich, Steffi

獲取全文 獲取全文 獲取全文

Quantifying Insulin Receptor Isoform Expression in FFPE Breast Tumors 由 Harrington, Sean C., Weroha, S. John, Reynolds, Carol, Suman, Vera J., Lingle, Wilma L., Haluska, Paul

獲取全文 獲取全文 獲取全文

Conventional Chemotherapy and Oncogenic Pathway Targeting in Ovarian Carcinosarcoma Using a Patient-Derived Tumorgraft 由 Glaser, Gretchen, Weroha, S. John, Becker, Marc A., Hou, Xiaonan, Enderica-Gonzalez, Sergio, Harrington, Sean C., Haluska, Paul

獲取全文 獲取全文 獲取全文

Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer 由 Becker, Marc A., Hou, Xiaonan, Tienchaianada, Piyawan, Haines, Brian B., Harrington, Sean C., Weroha, S. John, Sathyanarayanan, Sriram, Haluska, Paul

獲取全文 獲取全文 獲取全文

Heat Shock Protein 90 (HSP90) Inhibition Depletes LATS1 and LATS2, Two Regulators of the Mammalian Hippo Tumor Suppressor Pathway 由 Huntoon, Catherine J., Nye, Monica D., Geng, Liyi, Peterson, Kevin L., Flatten, Karen S., Haluska, Paul, Kaufmann, Scott H., Karnitz, Larry M.

獲取全文 獲取全文 獲取全文

Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors 由 Hubbard, Joleen, Erlichman, Charles, Toft, David O., Qin, Rui, Stensgard, Bridget A., Felten, Sara, Eyck, Cynthia Ten, Batzel, Gretchen, Ivy, S. Percy, Haluska, Paul

獲取全文 獲取全文 獲取全文

Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth 由 Becker, Marc A., Farzan, Thahir, Harrington, Sean C., Krempski, James W., Weroha, S. John, Hou, Xiaonan, Kalli, Kimberly R., Wong, Tai W., Haluska, Paul

獲取全文 獲取全文 獲取全文

Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma 由 Haluska, Paul, Worden, Frank, Olmos, David, Yin, Donghua, Schteingart, David, Batzel, Gretchen N., Luisa Paccagnella, M., de Bono, Johann S., Gualberto, Antonio, Hammer, Gary D.

獲取全文 獲取全文 獲取全文

IGFBP ratio confers resistance to IGF targeting and correlates with increased invasion and poor outcome in breast tumors 由 Becker, Marc A., Hou, Xiaonan, Harrington, Sean C., Weroha, S. John, Gonzalez, Sergio E., Jacob, Kristina A., Carboni, Joan M., Gottardis, Marco M., Haluska, Paul

獲取全文 獲取全文 獲取全文

Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts()() 由 Butler, Kristina A., Hou, Xiaonan, Becker, Marc A., Zanfagnin, Valentina, Enderica-Gonzalez, Sergio, Visscher, Daniel, Kalli, Kimberly R., Tienchaianada, Piyawan, Haluska, Paul, Weroha, S. John

獲取全文 獲取全文 獲取全文

HER receptor signaling confers resistance to the insulin-like growth factor 1 receptor inhibitor, BMS-536924 由 Haluska, Paul, Carboni, Joan M., Eyck, Cynthia Ten, Attar, Ricardo M., Hou, Xiaonan, Yu, Chunrong, Sagar, Malvika, Wong, Tai W., Gottardis, Marco M., Erlichman, Charles

獲取全文 獲取全文 獲取全文